×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Section 180: Copper and Zinc Homeostasis in CBS/PSP
therapeutic
2,128 words
KG: ent-dise-bfd8f32d
2026-03-24
section:therapeutics
kind:therapeutic
topic:cbs
topic:psp
topic:copper
topic:zinc
topic:metallothionein
topic:cuatsm
topic:metal-chelation
Contents
Section 180: Copper and Zinc Homeostasis in CBS/PSP
💊
Therapeutic Info
Name
Section 180: Copper and Zinc Homeostasis in CBS/PSP
Summary
Copper and zinc dysregulation in 4R-tauopathies, metallothionein biology, CuATSM imaging, metal chelation strategies for CBS/PSP treatment
Knowledge Graph
Related Hypotheses (7)
Purinergic Signaling Polarization Control
Score: 0.55
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Microglial Purinergic Reprogramming
Score: 0.48
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Extracellular Matrix Stiffness Modulation
Score: 0.43
Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu
Score: 0.44
Show 2 more
Related Analyses (8)
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · completed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Show 3 more
Related Experiments (15)
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40
Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.40
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.40
P2RY12 inhibition in atherosclerosis mouse model
validation · proposed · Score: 0.90
VSMC cholesterol efflux and P2RY12 signaling
exploratory · proposed · Score: 0.90
Microglial activation by bEVs via Piezo1
exploratory · proposed · Score: 0.90
P2RY12 regulation of autophagy in VSMCs
exploratory · proposed · Score: 0.90
Show 10 more
See Also (15)
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 6 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 6 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 6 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 6 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 6 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 6 hypotheses
ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 6 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 6 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 6 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 6 hypotheses
Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 6 hypotheses
T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 6 hypotheses
Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 6 hypotheses
synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 6 hypotheses
SUMOylation in Neurodegeneration
mechanism · Pages share 6 hypotheses
Show 10 more